← Open Payments lookup

KATHERINE LEATHERMAN: Open Payments

NPI 1598122426 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$766 in 36 payments from 9 companies in 2025. Trend: 2023 $444 · 2024 $360 · 2025 $766

Food & beverage: $766
CompanyPaymentsAmount
ABBVIE INC.12$253
Otsuka America Pharmaceutical, Inc.9$182
Axsome Therapeutics, Inc.3$86
Collegium Pharmaceutical, Inc.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Takeda Pharmaceuticals U.S.A., Inc.3$52
Lundbeck LLC1$28
Neuronetics, Inc.1$23
Vanda Pharmaceuticals Inc.1$17

Products named: VRAYLAR, REXULTI, Auvelity, Jornay PM, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX, NEUROSTAR TMS THERAPY SYSTEM.

Industry payments across OR — which companies pay providers there.